ENDOCARDIAL INVOLVEMENT IN SYSTEMIC AUTOIMMUNE DISEASES: PATHOPHYSIOLOGY, CLINICAL MANIFESTATIONS, AND MANAGEMENT
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5388Keywords:
Libman-Sacks Endocarditis, Antiphospholipid Syndrome, Cardiac Complications, Multidisciplinary ManagementAbstract
Purpose: The manuscript aims to highlight the clinical significance of Libman-Sacks endocarditis (LSE) in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). It emphasizes the importance of early diagnosis and multidisciplinary management to prevent severe cardiac complications and improve patient outcomes.
Methodology: A comprehensive review of recent literature and case studies was conducted, focusing on the pathogenesis, clinical presentation, diagnostic approaches, and management strategies for LSE in SLE and APS patients. The article synthesizes evidence from published research, including echocardiographic findings, laboratory markers, and therapeutic interventions
Findings: LSE is frequently underdiagnosed due to its subtle clinical manifestations. Echocardiography remains the gold standard for detection, revealing characteristic vegetations on heart valves. The manuscript identifies a strong association between LSE and thromboembolic events in SLE/APS patients. Multidisciplinary collaboration among cardiologists, rheumatologists, hematologists, and cardiac surgeons is crucial for optimal management. Anticoagulation and immunosuppressive therapy are central to treatment, with surgical intervention reserved for severe cases.
Conclusions: Early recognition and coordinated care are essential to reduce morbidity and mortality associated with LSE in SLE and APS. The article advocates for routine cardiac screening in high-risk patients and underscores the need for further research to refine diagnostic and therapeutic protocols.
References
Al Chalaby, S., Makhija, R. R., Sharma, A. N., Majid, M., Aman, E., Venugopal, S., & Amsterdam, E. A. (2022). Nonbacterial thrombotic endocarditis: Presentation, pathophysiology, diagnosis and management. Reviews in Cardiovascular Medicine, 23(4), 137. https://doi.org/10.31083/j.rcm2304137
Al-Sarraf, N., AlKharji, S., Hasan, M., & Alhumaidan, A. (2025). Libman-Sacks endocarditis of the mitral valve as a first presentation of systemic lupus erythematosus. Journal of Surgical Case Reports, 2025(12), rjaf989. https://doi.org/10.1093/jscr/rjaf989
Dobos, M. C., Ungurean, V., Costan, D. E., Russu, M., Ouatu, A., Morariu, P. C., Oancea, A. F., Godun, M. M., Floria, D.-E., Marcu, D. T., Baroi, G. L., Stanciu, S. M., Knieling, A., Tanase, D. M., Ancuta, C., & Floria, M. (2026). Cardiovascular involvement in systemic lupus erythematosus: Focus on arrhythmias. Diagnostics, 16(3), 372. https://doi.org/10.3390/diagnostics16030372
Ehsan, S., Afshar, S., Bakhtiari, S., Pourfallah, R., & Danaei Mehrabad, S. (2025). Systemic lupus erythematosus with catastrophic APS and Libman–Sacks endocarditis in a patient with autoimmune hemolytic anemia: A case report. Clinical Case Reports, 13(12), e71552. https://doi.org/10.1002/ccr3.71552
Hamidi, H., Darnige, L., & Dragon Durey, M.-A. (2026). Complement involvement in antiphospholipid syndrome. Immunology Letters, 279, 107148. https://doi.org/10.1016/j.imlet.2026.107148
Huo, L., Hou, C., Cao, C., Peng, X., & Liu, J. (2026). Primary antiphospholipid syndrome complicated by recurrent acute ST-elevation myocardial infarction: A case report. Frontiers in Cardiovascular Medicine, 12, 1656890. https://doi.org/10.3389/fcvm.2025.1656890
Li, Y., Huang, Q., & Shen, R. (2025). Catastrophic antiphospholipid syndrome following surgery for Libman–Sacks endocarditis: A case report and literature review. Journal of Cardiothoracic Surgery, 20(1), 442. https://doi.org/10.1186/s13019-025-03692-4
Merimi, I., Zinoune, L., Bazid, Z., Ismaili, N., & Elouafi, N. (2024). Spontaneous coronary artery dissection and valvular disease revealing an antiphospholipid syndrome in a young woman: Case report. Radiology Case Reports, 19(12), 6047–6052. https://doi.org/10.1016/j.radcr.2024.08.080
Morecroft, R., Phillipps, J., Majithia, V., & Mumtaz, S. (2026). Catastrophic antiphospholipid syndrome: A rare but life-threatening thrombotic storm—A case report and literature review. Case Reports in Rheumatology, 2026(1), 8852169. https://doi.org/10.1155/crrh/8852169
Neupane, R., Sivakumar, B., Mathew, E., & Kesselman, M. M. (2026). Cardiac complications in systemic lupus erythematosus: A systematic review of diagnostic and prognostic gaps. Cureus. https://doi.org/10.7759/cureus.102966
Ota, H., Yoshizaki, T., Nakayama, S., Wakamiya, R., Matsunaga, A., Takeo, H., & Masuoka, K. (2026). Catastrophic antiphospholipid syndrome with eosinophilia mimicking hypereosinophilic syndromes with disseminated intravascular coagulation: A case report. Journal of Medical Case Reports, 20(1), 127. https://doi.org/10.1186/s13256-026-05851-0
Pallinti, P., Singulane, C. C., Wang, S., Carlson, D. K., Morsy, M., Philips, S., Lusa, A. L., & Rodriguez-Lozano, P. (2026). Multimodality imaging and multidisciplinary diagnosis of hydroxychloroquine cardiotoxicity with CMD and Libman-Sacks endocarditis. JACC: Case Reports, 31(1), 105940. https://doi.org/10.1016/j.jaccas.2025.105940
Riancho-Zarrabeitia, L., Martínez-Taboada, V., Rúa-Figueroa, I., Alonso, F., Galindo-Izquierdo, M., Ovalles, J., Olivé-Marqués, A., Vázquez, N. M., Calvo-Alén, J., Menor-Almagro, R., Tomero-Muriel, E., Uriarte-Isacelaya, E., Botenau, A., Andres, M., Freire-González, M., Soler, G. S., Ruiz-Lucea, E., Ibáñez-Barceló, M., Castellví, I., . . . Pego-Reigosa, J. M. (2021). Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients? Clinical and Experimental Rheumatology.
Satish, V., Maliha, M., Rosenbaum, S., Chi, K.-Y., & Leiderman, E. (2024). Multi-disciplinary approach in Libman-Sacks endocarditis. Journal of the American College of Cardiology, 83(13), 2985. https://doi.org/10.1016/S0735-1097(24)04975-1
Sultan, W., Shibli, M., Madhu, V., Wilson, M., & Burmeister, J. (2025). Nonbacterial thrombotic endocarditis (Libman-Sacks) as a complication of metastatic pancreatic cancer: A case report of diagnostic and therapeutic challenges. Cureus. https://doi.org/10.7759/cureus.96625
Tang, P.-T. (n.d.). Recurrent ischaemic strokes as a first presentation of Libman–Sacks endocarditis with an atypically massive mitral vegetation resulting in severe valvular regurgitation: A case report.
Tayem, M. G., Shahin, L., Shook, J., & Kesselman, M. M. (2022). A review of cardiac manifestations in patients with systemic lupus erythematosus and antiphospholipid syndrome with focus on endocarditis. Cureus. https://doi.org/10.7759/cureus.21698
Van Der Woude, S. F. S., Valentijn, F. A., Antoni, M. L., Huisman, S. J., & Van Vliet, M. (2026). Severe aortic stenosis and dual valve vegetations. JACC: Case Reports, 31(3), 106227. https://doi.org/10.1016/j.jaccas.2025.106227
Velasquez-Orozco, G. A. (n.d.). Isolated tricuspid Libman–Sacks endocarditis in a patient with systemic lupus erythematosus and antiphospholipid syndrome: Case report.
Yang, Z., Gong, W., Liu, Y., & Zheng, M. (2025). Left ventricle Libman-Sacks endocarditis secondary to systemic lupus erythematosus and antiphospholipid syndrome: A case report. American Journal of Case Reports, 26. https://doi.org/10.12659/AJCR.949826
Zaman, M. A., Sohail, M. O., Sbeitan, I., & Aldergash, S. M. (2025). Prolonged antibiotics versus prolonged anticoagulation: A case report of Libman-Sacks endocarditis. Cureus. https://doi.org/10.7759/cureus.83203
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Karol Szyprowski, Jakub Skrzypek, Natalia Fidut, Kamila Zioło, Weronika Zarzycka, Maciej Kisielewski, Julia Wawerska, Weronika Wrzosek, Bartosz Okliński, Mateusz Zugaj

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

